Metabolic profiling of triple-negative breast cancer cells reveals metabolic vulnerabilities

BACKGROUND: Among breast cancers, the triple-negative breast cancer (TNBC) subtype has the worst prognosis with no approved targeted therapies and only standard chemotherapy as the backbone of systemic therapy. Unique metabolic changes in cancer progression provide innovative therapeutic opportuniti...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Metab
Main Authors: Lanning, Nathan J., Castle, Joshua P., Singh, Simar J., Leon, Andre N., Tovar, Elizabeth A., Sanghera, Amandeep, MacKeigan, Jeffrey P., Filipp, Fabian V., Graveel, Carrie R.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5568171/
https://ncbi.nlm.nih.gov/pubmed/28852500
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40170-017-0168-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados